Organosol

Mannitol, one of the active ingredients in Organosol, is an excipient presented as a sterile aqueous solution for parenteral use. It functions as an osmotic agent and stabilizer in a range of pharmaceutical preparations, helping to maintain isotonicity and protect sensitive active substances during storage and administration. Organosol also contains histidine, histidine hydrochloride monohydrate, tryptophan and magnesium chloride hexahydrate, which together provide buffering capacity, amino‑acid support and electrolyte balance for optimal formulation performance.

GNH USA supplies Organosol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Organosol is employed as a solvent and isotonic agent in pharmaceutical and laboratory formulations, supporting the stability and delivery of active compounds. - Parenteral drug formulations: provides isotonicity and stabilizes active ingredients for safe intravenous administration. - Cell culture media: supplies osmotic balance and essential amino acids to maintain cell viability in vitro. - Diagnostic reagents: serves as a diluent that ensures consistent assay performance and reagent stability.

Organosol may cause adverse reactions related to its excipient components, particularly when administered intravenously.

Common Side Effects: - Injection site pain or irritation. - Transient flushing or warmth at the infusion site. - Mild electrolyte disturbances (e.g., slight hypermagnesemia). - Headache or dizziness. - Nausea. - Mild hypersensitivity skin rash.

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction. - Significant electrolyte imbalance leading to cardiac arrhythmia. - Renal impairment due to mannitol accumulation. - Severe hypotension. - Pulmonary edema from rapid infusion. - Hemolysis in patients with G6PD deficiency.

Organosol should be used with attention to patient-specific factors and handling requirements. - Assess renal function: avoid rapid infusion in patients with compromised kidney function. - Monitor electrolytes: check serum magnesium and osmolarity during prolonged therapy. - Evaluate allergy history: screen for hypersensitivity to any component. - Use appropriate infusion rate: adhere to recommended administration speeds to prevent hemodynamic shifts. - Verify compatibility: ensure no precipitation when mixed with other intravenous drugs. - Store at ambient temperature: keep below 25°C, protect from moisture and direct sunlight, and retain in original sealed container.

Organosol can interact with certain medications and solutions, affecting safety or efficacy.

Major Interactions (Avoid): - High‑dose mannitol-containing therapies: risk of cumulative osmotic load and renal stress. - Calcium‑containing solutions: may precipitate with magnesium chloride, causing infusion line blockage. - Acidic drugs: can destabilize the histidine buffer, altering pH.

Moderate Interactions (Monitor Closely): - Loop diuretics: may enhance electrolyte shifts, requiring monitoring. - Anticoagulants: osmotic changes could affect plasma volume, influencing drug concentrations. - Blood products: ensure compatible osmolarity to prevent hemolysis.